Teva in talks with Covid-19 vaccine manufacturers to co-produce shots
10.02.21 | Reuters and CTech
This site uses cookies to ensure the best viewing experience for our readers.
Kare Schultz
4 stories about Kare Schultz
Teva beats analysts predictions with increased revenues from growth drivers
10.02.21 | Sophie Shulman
Generic Drugmaker Teva Says Profit Will Continue to Drop in 2018
08.02.18 | Dror Reich
New CEO to Break Teva’s Copaxone Habit
11.09.17 | Sophie Shulman, Dror Reich
Tag does not exist. Please try again.